Literature DB >> 26207889

Curcumin Inhibits Neuronal Loss in the Retina and Elevates Ca²⁺/Calmodulin-Dependent Protein Kinase II Activity in Diabetic Rats.

Jun Li1, Peipei Wang1, Yanxia Zhu1, Zhen Chen1, Tianyan Shi1, Wensheng Lei1, Songping Yu1.   

Abstract

PURPOSE: To determine whether curcumin offers neuroprotection to minimize the apoptosis of neural cells in the retina of diabetic rats.
METHODS: Streptozotocin (STZ)-induced diabetic rats and control rats were used in this study. A subgroup of STZ-induced diabetic rats were treated with curcumin for 12 weeks. Retinal histology, apoptosis of neural cells in the retina, electroretinograms, and retinal glutamate content were evaluated after 12 weeks. Retinal levels of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII), phospho-CaMKII (p-CaMKII), and cleaved caspase-3 were determined by Western blot analysis.
RESULTS: The amplitudes a-wave, b-wave, and oscillatory potential were reduced by diabetes, but curcumin treatment suppressed this reduction of amplitudes. Curcumin also prevented cell loss from the outer nuclear, inner nuclear, and ganglion cell layers. Apoptosis of retinal neurons was detected in diabetic rats. The concentration of glutamate in the retina was higher in diabetic rats, but was significantly reduced in the curcumin-treated group. Furthermore, p-CaMKII and cleaved caspase-3 expression were upregulated in the diabetic retina, but reduced in curcumin-treated rats.
CONCLUSIONS: Curcumin attenuated diabetes-induced apoptosis in retinal neurons by reducing the glutamate level and downregulating CaMKII. Thus, curcumin might be used to prevent neuronal damage in the retina of patients with diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26207889      PMCID: PMC4642824          DOI: 10.1089/jop.2015.0006

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  56 in total

1.  Curcumin protects against NMDA-induced toxicity: a possible role for NR2A subunit.

Authors:  Andrea Matteucci; Roberta Cammarota; Silvia Paradisi; Monica Varano; Maria Balduzzi; Lanfranco Leo; Gian C Bellenchi; Chiara De Nuccio; Giovanna Carnovale-Scalzo; Giovanni Scorcia; Claudio Frank; Cinzia Mallozzi; Annamaria M Di Stasi; Sergio Visentin; Fiorella Malchiodi-Albedi
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-22       Impact factor: 4.799

2.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

Authors:  A J Barber; E Lieth; S A Khin; D A Antonetti; A G Buchanan; T W Gardner
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

3.  Expression of apoptosis markers in the retinas of human subjects with diabetes.

Authors:  Ahmed M Abu-El-Asrar; Lieve Dralands; Luc Missotten; Ibrahim A Al-Jadaan; Karel Geboes
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-08       Impact factor: 4.799

4.  Role of Ca2+/calmodulin-dependent protein kinase II in development of vascular dysfunction in diabetic rats with hypertension.

Authors:  Mariam H M Yousif; Saghir Akhtar; Thomas Walther; Ibrahim F Benter
Journal:  Cell Biochem Funct       Date:  2008 Mar-Apr       Impact factor: 3.685

5.  Glutamate-induced NFkappaB activation in the retina.

Authors:  Wei Fan; Nigel G F Cooper
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-03       Impact factor: 4.799

6.  Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy.

Authors:  Hille W van Dijk; Pauline H B Kok; Mona Garvin; Milan Sonka; J Hans Devries; Robert P J Michels; Mirjam E J van Velthoven; Reinier O Schlingemann; Frank D Verbraak; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-17       Impact factor: 4.799

7.  {beta}-Amyloid impairs AMPA receptor trafficking and function by reducing Ca2+/calmodulin-dependent protein kinase II synaptic distribution.

Authors:  Zhenglin Gu; Wenhua Liu; Zhen Yan
Journal:  J Biol Chem       Date:  2009-02-24       Impact factor: 5.157

8.  Curcumin reverses impaired cognition and neuronal plasticity induced by chronic stress.

Authors:  Ying Xu; Dan Lin; Shan Li; Gaowen Li; Subramaniam G Shyamala; Philip A Barish; Matthew M Vernon; Jianchun Pan; William O Ogle
Journal:  Neuropharmacology       Date:  2009-06-21       Impact factor: 5.250

9.  Effects of curcumin on retinal oxidative stress and inflammation in diabetes.

Authors:  Renu A Kowluru; Mamta Kanwar
Journal:  Nutr Metab (Lond)       Date:  2007-04-16       Impact factor: 4.169

10.  Curcumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications.

Authors:  M Balasubramanyam; A Adaikala Koteswari; R Sampath Kumar; S Finny Monickaraj; J Uma Maheswari; V Mohan
Journal:  J Biosci       Date:  2003-12       Impact factor: 2.795

View more
  4 in total

Review 1.  The functions of Ca2+/calmodulin-dependent protein kinase II (CaMKII) in diabetes progression.

Authors:  Khaled Benchoula; Ahmed Mediani; Wong Eng Hwa
Journal:  J Cell Commun Signal       Date:  2022-05-12       Impact factor: 5.782

Review 2.  Inherited Retinal Dystrophies: Role of Oxidative Stress and Inflammation in Their Physiopathology and Therapeutic Implications.

Authors:  Isabel Pinilla; Victoria Maneu; Laura Campello; Laura Fernández-Sánchez; Natalia Martínez-Gil; Oksana Kutsyr; Xavier Sánchez-Sáez; Carla Sánchez-Castillo; Pedro Lax; Nicolás Cuenca
Journal:  Antioxidants (Basel)       Date:  2022-05-30

3.  Neuronal Epac1 mediates retinal neurodegeneration in mouse models of ocular hypertension.

Authors:  Wei Liu; Yonju Ha; Fan Xia; Shuang Zhu; Yi Li; Shuizhen Shi; Fang C Mei; Kevin Merkley; Gianmarco Vizzeri; Massoud Motamedi; Xiaodong Cheng; Hua Liu; Wenbo Zhang
Journal:  J Exp Med       Date:  2020-04-06       Impact factor: 14.307

Review 4.  Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives.

Authors:  Xiao-Yu Xu; Xiao Meng; Sha Li; Ren-You Gan; Ya Li; Hua-Bin Li
Journal:  Nutrients       Date:  2018-10-19       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.